ACE inhibitors are considered one of the standard treatments for obese and diabetic patients with renal disease (Agodoa et al., 2001; Jafar et al., 2001; Progression of Chronic Kidney Disease, 2003; Chu et al., 2021). Here, ACE is linked to kidney disorder.